We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Keytruda Gets FDA Approval for Esophageal or Gastroesophageal Cancer
Keytruda Gets FDA Approval for Esophageal or Gastroesophageal Cancer
The FDA has approved Merck’s blockbuster cancer drug Keytruda (pembrolizumab) for certain patients with esophageal or gastroesophageal cancer taken in combination with platinum and fluoropyrimidine-based chemotherapy.